Davide Ottaviani

629 total citations
10 papers, 147 citations indexed

About

Davide Ottaviani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Davide Ottaviani has authored 10 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Davide Ottaviani's work include Bone health and treatments (3 papers), Cancer Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Davide Ottaviani is often cited by papers focused on Bone health and treatments (3 papers), Cancer Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Davide Ottaviani collaborates with scholars based in Italy and Portugal. Davide Ottaviani's co-authors include L Buffoni, Antonio Mussa, Riccardo Ferracini, Lisa Bonello, Ilaria Roato, Silvia Colucci, Roberto Manfredi, Maria Grano, Giacomina Brunetti and Libero Ciuffreda and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Davide Ottaviani

8 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Ottaviani Italy 6 77 48 27 15 13 10 147
Michał Piotr Budzik Poland 8 66 0.9× 60 1.3× 34 1.3× 10 0.7× 5 0.4× 22 190
Ryota Kawamura Japan 9 99 1.3× 114 2.4× 64 2.4× 18 1.2× 15 1.2× 23 295
Yutong Chen China 10 33 0.4× 159 3.3× 26 1.0× 24 1.6× 14 1.1× 23 228
Alvydas Česas Lithuania 7 88 1.1× 82 1.7× 26 1.0× 8 0.5× 2 0.2× 14 161
Karolin Walter Germany 5 61 0.8× 98 2.0× 9 0.3× 16 1.1× 10 0.8× 8 157
Maria Lucia Sarnicola Italy 3 55 0.7× 56 1.2× 20 0.7× 34 2.3× 4 0.3× 6 177
Pooria Nakhaei Iran 6 81 1.1× 69 1.4× 20 0.7× 35 2.3× 4 0.3× 14 185
Cynthia McCully United States 8 86 1.1× 75 1.6× 82 3.0× 13 0.9× 4 0.3× 19 256
Ju Hee Kim South Korea 8 56 0.7× 69 1.4× 31 1.1× 15 1.0× 4 0.3× 19 166
Maryam Bagherzadeh Canada 5 91 1.2× 131 2.7× 36 1.3× 9 0.6× 5 0.4× 6 267

Countries citing papers authored by Davide Ottaviani

Since Specialization
Citations

This map shows the geographic impact of Davide Ottaviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Ottaviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Ottaviani more than expected).

Fields of papers citing papers by Davide Ottaviani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Ottaviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Ottaviani. The network helps show where Davide Ottaviani may publish in the future.

Co-authorship network of co-authors of Davide Ottaviani

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Ottaviani. A scholar is included among the top collaborators of Davide Ottaviani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Ottaviani. Davide Ottaviani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ottaviani, Davide, et al.. (2019). Eco-friendly cyclohexane oxidation by a V-scorpionate complex immobilized at hierarchical MOR zeolite. Catalysis Today. 348. 37–44. 16 indexed citations
2.
Comandone, Alessandro, et al.. (2017). Metastatic soft tissue sarcomas (STS) in elderly patients: 18 years of monoinstitutional experience.. Journal of Clinical Oncology. 35(15_suppl). e22528–e22528.
3.
Boglione, Antonella, et al.. (2016). Systemic therapy in clear cell sarcoma (CCS). Annals of Oncology. 27. iv99–iv99. 3 indexed citations
4.
Santini, Daniele, Salvatore Intagliata, Toni Ibrahim, et al.. (2013). Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey.. Journal of Clinical Oncology. 31(15_suppl). e19084–e19084.
5.
Santini, Daniele, Giuseppe Procopio, Camillo Porta, et al.. (2012). Natural history of malignant bone disease in renal cancer: Final results of an Italian bone metastases survey.. Journal of Clinical Oncology. 30(15_suppl). 4627–4627. 7 indexed citations
6.
Daniele, Lorenzo, Sara Mariani, Davide Ottaviani, et al.. (2008). Added Value of Combined Gene and Protein Expression of CK20 and CEA in Non—macroscopically Involved Lymph Nodes of Colorectal Cancer. International Journal of Surgical Pathology. 17(2). 93–98. 9 indexed citations
7.
Roato, Ilaria, Giacomina Brunetti, Maria Grano, et al.. (2006). IL-7 Up-Regulates TNF-α-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor. PLoS ONE. 1(1). e124–e124. 96 indexed citations
8.
Buffoni, L, C. Barone, Davide Ottaviani, et al.. (2006). Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial. Lung Cancer. 54(3). 353–357. 6 indexed citations
9.
Berruti, Alfredo, L Buffoni, Alfredo Addeo, et al.. (2004). Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. Lung Cancer. 47(2). 269–275. 9 indexed citations
10.
Giorgi, Raffaele De, et al.. (1988). Evidence of interaction between morphine and bleomycin. Note II: Antagonism in morphine-dependent rats. Pharmacological Research Communications. 20. 287–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026